시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 특수 의약품 시장 보고서(2025년)
Specialty Pharmaceuticals Global Market Report 2025
상품코드 : 1811034
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,362,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,196,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,031,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 특수 의약품 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 연평균 복합 성장률(CAGR) 9.7%로 확대되어 8,611억 8,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 맞춤형 의료 채택 확대, 생물 제제 및 바이오시밀러 투자 증가, 희귀질환 확산, 신흥국 시장의 건강 관리 인프라 확대, 특수 의약품 파이프라인 개발에 대한 관심 증가 등에 기인할 수 있습니다. 이 기간에 예상되는 주요 동향으로는 생물제제와 유전자 치료의 진보, 첨단 약물 전달 기술, 맞춤형 의료의 혁신, 디지털 헬스와 AI 통합, 바이오시밀러 개발의 진전 등이 있습니다.

만성 질환의 유병률 증가는 특수 의약품 시장의 향후 성장을 이끌 것으로 예측됩니다. 만성 질환은 보통 1년 이상 지속되는 장기 건강 상태이며 지속적인 의료가 필요하거나 일상 생활을 제한합니다. 고령자는 당뇨병, 심장병, 관절염 등의 질환에 걸리기 쉽기 때문에 이 증가는 인구 고령화에 기인하는 것이 큽니다. 특수 의약품은 특히 표준 치료로는 충분하지 않은 경우 환자의 결과와 삶의 질을 향상시키는 목표로 하는 매우 효과적인 치료를 제공함으로써 만성 질환 관리를 지원합니다. 예를 들어, 2024년 6월 미국 의료 도서관인 National Library of Medicine은 하나 이상의 만성 질환을 앓고 살아가는 50세 이상의 미국인 수는 2050년까지 거의 두배로 늘어나 약 1억 4,266만명에 달할 것으로 예상되며, 그 증가율은 99.5%로 현저합니다. 그 결과 만성질환의 만연이 전문의약품 시장 확대에 박차를 가하고 있습니다.

특수 의약품 시장의 주요 기업은 환자 참여도를 높이고 치료 준수를 강화하며 케어 배달을 최적화하기 위해 통합 디지털 케어 공간과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 통합 디지털 케어 스페이스는 디지털 헬스 기술을 갖춘 가상 또는 물리적 환경으로, 환자, 헬스 케어 프로바이더, 서포트 서비스를 접속하는 것으로, 원격지와 대면에서의 협조 케어를 촉진해, 결국 치료 결과와 효율을 개선합니다. 예를 들어, 2024년 4월 미국의 약국 주도형 건강 웰니스 기업인 Walgreens Boots Alliance, Inc.는 새롭게 통합된 전문 약국 부문에서 유전자 및 세포 치료 서비스를 시작했습니다. 이 노력은 환자의 케어와 치료 관리를 강화하는 것을 목적으로 하여 첨단 유전자 및 세포 치료에 초점을 맞추었습니다. 이 시설은 이러한 첨단 요법에 필요한 복잡한 물류와 전문적인 요구 사항을 지원하며 특수 의약품 부문의 존재를 확대하는 Walgreens의 헌신적인 자세를 보여줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Specialty pharmaceuticals refer to a category of medications that are high-cost, complex, and often require special handling, administration, or monitoring. These drugs are primarily used to treat chronic, rare, or complex conditions such as cancer, autoimmune diseases, and rare genetic disorders.

The primary drug types of specialty pharmaceuticals include biologics, biosimilars, orphan drugs, small molecules, and others. Biologics are complex medicines derived from living organisms or their components, used to treat various diseases. The routes of administration include oral, injectable, intranasal, transdermal, and inhalation, covering therapeutic areas such as oncology, autoimmune diseases, neurology, infectious diseases, rare genetic disorders, and more. Distribution channels encompass both online and offline platforms, with key end users being hospitals, specialty clinics, homecare settings, and pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The specialty pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides specialty pharmaceuticals market statistics, including the specialty pharmaceuticals industry global market size, regional shares, competitors with the specialty pharmaceuticals market share, detailed specialty pharmaceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the specialty pharmaceuticals industry. This specialty pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The specialty pharmaceuticals market size has grown rapidly in recent years. It will grow from $540.10 billion in 2024 to $594.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth observed during the historic period can be attributed to rising demand for targeted therapies, an increasing prevalence of chronic diseases, a surge in biopharmaceutical innovations, a rise in specialty drug approvals, and growing healthcare expenditure.

The specialty pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to$861.18 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine, rising investments in biologics and biosimilars, a growing prevalence of rare diseases, expanding healthcare infrastructure in emerging markets, and an increasing focus on specialty drug pipeline development. Major trends expected in this period include advancements in biologics and gene therapies, advanced drug delivery technologies, innovations in personalized medicine, integration of digital health and AI, and progress in biosimilar development.

The rising prevalence of chronic diseases is expected to drive growth in the specialty pharmaceuticals market moving forward. Chronic diseases are long-term health conditions that usually last a year or more, requiring ongoing medical care or limiting daily activities. This increase is largely attributed to the aging population, as older individuals are more prone to conditions like diabetes, heart disease, and arthritis. Specialty pharmaceuticals assist in managing chronic diseases by offering targeted, highly effective treatments that improve patient outcomes and quality of life, especially when standard therapies fall short. For example, in June 2024, the National Library of Medicine, a US-based medical library, reported that the number of Americans aged 50 and above living with at least one chronic condition is expected to nearly double by 2050, reaching about 142.66 million, a remarkable 99.5% rise. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the specialty pharmaceuticals market.

Leading companies in the specialty pharmaceuticals market are concentrating on developing innovative solutions like integrated digital care spaces to boost patient engagement, enhance treatment adherence, and optimize care delivery. Integrated digital care spaces are either virtual or physical environments equipped with digital health technologies that facilitate coordinated remote and in-person care by connecting patients, healthcare providers, and support services, ultimately improving treatment outcomes and efficiency. For instance, in April 2024, Walgreens Boots Alliance, Inc., a US-based pharmacy-led health and wellness company, launched gene and cell therapy services within its newly integrated specialty pharmacy division. This initiative focuses on advanced gene and cell therapies, aiming to enhance patient care and treatment management. The facility supports the complex logistics and specialized requirements of these advanced therapies, demonstrating Walgreens' dedication to expanding its presence in the specialty pharmaceuticals sector.

In October 2022, Pfizer Inc., a US-based pharmaceutical company, acquired Biohaven Pharmaceuticals for $11.6 billion. This acquisition allows Pfizer to strengthen its neurology portfolio by obtaining full global rights to Biohaven's migraine medication Nurtec ODT and its innovative CGRP-based pipeline. Biohaven Pharmaceuticals Inc., also US-based, specializes in developing treatments for rare neurological and immunological disorders.

Major players in the specialty pharmaceuticals market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Apotex Inc., Cipla Limited, Hikma Pharmaceuticals plc, United Therapeutics Corporation, Mallinckrodt plc, Biocon Biologics Limited, Medicure Inc.

North America was the largest region in the specialty pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in specialty pharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the specialty pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specialty pharmaceuticals market consists of sales of personalized medicine, rare disease treatments, and cellular immunotherapies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Specialty Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on specialty pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for specialty pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The specialty pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Specialty Pharmaceuticals Market Characteristics

3. Specialty Pharmaceuticals Market Trends And Strategies

4. Specialty Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Specialty Pharmaceuticals Growth Analysis And Strategic Analysis Framework

6. Specialty Pharmaceuticals Market Segmentation

7. Specialty Pharmaceuticals Market Regional And Country Analysis

8. Asia-Pacific Specialty Pharmaceuticals Market

9. China Specialty Pharmaceuticals Market

10. India Specialty Pharmaceuticals Market

11. Japan Specialty Pharmaceuticals Market

12. Australia Specialty Pharmaceuticals Market

13. Indonesia Specialty Pharmaceuticals Market

14. South Korea Specialty Pharmaceuticals Market

15. Western Europe Specialty Pharmaceuticals Market

16. UK Specialty Pharmaceuticals Market

17. Germany Specialty Pharmaceuticals Market

18. France Specialty Pharmaceuticals Market

19. Italy Specialty Pharmaceuticals Market

20. Spain Specialty Pharmaceuticals Market

21. Eastern Europe Specialty Pharmaceuticals Market

22. Russia Specialty Pharmaceuticals Market

23. North America Specialty Pharmaceuticals Market

24. USA Specialty Pharmaceuticals Market

25. Canada Specialty Pharmaceuticals Market

26. South America Specialty Pharmaceuticals Market

27. Brazil Specialty Pharmaceuticals Market

28. Middle East Specialty Pharmaceuticals Market

29. Africa Specialty Pharmaceuticals Market

30. Specialty Pharmaceuticals Market Competitive Landscape And Company Profiles

31. Specialty Pharmaceuticals Market Other Major And Innovative Companies

32. Global Specialty Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Specialty Pharmaceuticals Market

34. Recent Developments In The Specialty Pharmaceuticals Market

35. Specialty Pharmaceuticals Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기